← Open Payments lookup

AHMAD BILAL: Open Payments

NPI 1487747424 · CANANDAIGUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,165 in 56 payments from 17 companies in 2025. Trend: 2023 $2,160 · 2024 $974 · 2025 $1,165

Food & beverage: $1,165
CompanyPaymentsAmount
ABBVIE INC.12$248
Neurocrine BioSciences, Inc.5$175
Otsuka America Pharmaceutical, Inc.6$112
Takeda Pharmaceuticals U.S.A., Inc.5$84
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$79
E.R. Squibb & Sons, L.L.C.4$69
Janssen Pharmaceuticals, Inc3$62
Alkermes, Inc.3$61
Almatica Pharma LLC2$42
Axsome Therapeutics, Inc.2$36

Products named: VRAYLAR, INGREZZA, REXULTI, TRINTELLIX, CAPLYTA, COBENFY, INVEGA, LOREEV XR.

Industry payments across NY — which companies pay providers there.